Colorectal cancer Trials in Maplewood, United States
Conditions / Colorectal cancer / Maplewood, United States
Clinical trials for Colorectal cancer investigate a range of treatment strategies and patient populations.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE3 |
| NCT01189227 | Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | TERMINATED | PHASE3 |
| NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | COMPLETED | PHASE3 |
| NCT00410579 | Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | COMPLETED | — |
| NCT00321828 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery | COMPLETED | PHASE2 |
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | UNKNOWN | PHASE2/PHASE3 |
| NCT01011478 | Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery | TERMINATED | PHASE3 |
| NCT01079780 | Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy | COMPLETED | PHASE2 |
| NCT02164916 | S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer | COMPLETED | PHASE2 |
| NCT01150045 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | UNKNOWN | PHASE3 |